- Home
- SNTI vs NAAS Comparison
SNTI vs NAAS Comparison
Compare SNTI & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- NAAS
- Stock Information
- Founded
- SNTI 2016
- NAAS 2019
- Country
- SNTI United States
- NAAS China
- Employees
- SNTI N/A
- NAAS N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- NAAS Other Specialty Stores
- Sector
- SNTI Health Care
- NAAS Consumer Discretionary
- Exchange
- SNTI Nasdaq
- NAAS Nasdaq
- Market Cap
- SNTI 21.3M
- NAAS 18.9M
- IPO Year
- SNTI N/A
- NAAS 2017
- Fundamental
- Price
- SNTI $3.96
- NAAS $1.63
- Analyst Decision
- SNTI Strong Buy
- NAAS
- Analyst Count
- SNTI 1
- NAAS 0
- Target Price
- SNTI $12.00
- NAAS N/A
- AVG Volume (30 Days)
- SNTI 30.3K
- NAAS 4.4M
- Earning Date
- SNTI 03-20-2025
- NAAS 03-27-2025
- Dividend Yield
- SNTI N/A
- NAAS N/A
- EPS Growth
- SNTI N/A
- NAAS N/A
- EPS
- SNTI N/A
- NAAS N/A
- Revenue
- SNTI N/A
- NAAS $43,258,393.00
- Revenue This Year
- SNTI $11.52
- NAAS $19.53
- Revenue Next Year
- SNTI $78.57
- NAAS $151.36
- P/E Ratio
- SNTI N/A
- NAAS N/A
- Revenue Growth
- SNTI N/A
- NAAS 50.34
- 52 Week Low
- SNTI $1.52
- NAAS $1.30
- 52 Week High
- SNTI $16.94
- NAAS $34.20
- Technical
- Relative Strength Index (RSI)
- SNTI 45.36
- NAAS 51.51
- Support Level
- SNTI $3.92
- NAAS $1.32
- Resistance Level
- SNTI $4.50
- NAAS $1.95
- Average True Range (ATR)
- SNTI 0.26
- NAAS 0.24
- MACD
- SNTI -0.03
- NAAS 0.03
- Stochastic Oscillator
- SNTI 20.59
- NAAS 27.05
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with their gene circuit platform technologies to fight challenging diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators. wide range of offline services that simplify the daily operations of charging station operators, and of non-charging services such as food and beverage services to station operators.